Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Daniel  Orfe, MS

Daniel Orfe, MS

President and CEO

Regulatory eSubmissions, LLC, United States

Learning Objective : Discuss the approach three life science companies take when utilizing outsource partners for eSubmission production; Describe how ongoing mergers and acquisitions impact eSubmission outsourcing strategy; Identify what to consider when choosing an eCTD outsource partner.

Speaker(s)

Daniel  Orfe, MS

Several Regulatory Operations Groups Integrated Into One: Changes to the Who, What, Where, When, Why and How of Submission Outsourcing

Daniel Orfe, MS

Regulatory eSubmissions, LLC, United States

President and CEO

Karen  Towns

Submission Outsourcing: Stop Working For it, Make it Work For You

Karen Towns

Pfizer, United States

VP, Global Head of Publishing & Product License Support

Cortney A Gilbert, MBA, MS

In/Out Sourcing: Risks and Benefits of a Hybrid Sourcing Model

Cortney A Gilbert, MBA, MS

Merck & Co., Inc., United States

Associate Director, Global Regulatory Operations

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.